A study found semaglutide was associated with nearly 40 percent fewer asthma attacks and 20 percent fewer COPD flare-ups, while three other GLP-1 drugs showed no such association.
youtu.be/X-mMZk2gSqI
#Semaglutide #Ozempic #Wegovy #GLP1 #GLP1Drugs #Asthma #COPD #LungHealth #RespiratoryHealth
